The Chemours Company

CC Basic Materials Specialty Chemicals

The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue fell 1.49%, EPS grew 28.7%, free cash flow grew 128.0% and total debt fell 6.47%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

12.66 0.25 −1.94%
Market cap
$1.9B
P/E
0.0×
Fwd P/E
16.9×
Dividend yield
2.76%
F-score
4/9
Altman Z
1.35
Beneish M
−2.91
Dividend safety
0/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

3 4 4 4
ROE
(70.49%) (93.80%) (103.02%) (318.32%)
ROA
(4.50%) (5.18%) (5.59%) (4.15%)
ROIC
0.24% (1.08%) (1.50%) (2.22%)
Return on Tangible Assets
(7.65%) (8.79%) (9.41%) (7.13%)
Average Days of Receivables
59.23 42.67 47.59 57.11
Free Cash Flow per Share
(0.05) 0.34 1.02 1.44
Free Cash Flow
(8.00) 51.00 154.00 218.00
Capital Expenditures
(273.00) (213.00) (178.00) (179.00)
Other line items
Cash ROIC
(0.16%) 1.01% 3.13% 4.85%
Accounts Receivable Turnover
6.15 8.02 7.20 6.21
Accounts Payable Turnover
4.59 4.65 5.21 5.01
Inventory Turnover
3.23 3.24 3.20 3.26
Average Days of Payables
78.30 70.98 65.79 69.64
Days of Inventory on Hand
117.03 116.73 113.42 107.92
Tax Rate
0.70 0.39 0.37 4.87
Research and Development Expense of Revenue
1.83% 1.86% 1.84% 1.83%
Selling, General and Administrative Expense of Revenue
14.15% 13.76% 14.14% 14.97%
Share Based Compensation of Revenue
0.34% 0.36% 0.40% 0.40%
Interest Coverage
0.06 (0.24) (0.33) (0.41)
Operating CF/Net income
(0.78) (0.68) (0.81) (1.31)
Depreciation/Fixed assets
0.11 0.11 0.11 0.11
Capex/Depreciation
(0.79) (0.61) (0.52) (0.54)
Revenue per Share
38.82 38.66 38.61 38.33
Operating CF per Share
1.76 1.76 2.20 2.63
Capex per Share
(1.82) (1.42) (1.18) (1.18)
Capex to Sales
0.05 0.04 0.03 0.03

Fold the line items

Columns are period end dates